Cite

HARVARD Citation

    Payne, J. et al. (2022). A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency. Haemophilia. 28 (4), pp. 523-531. [Online]. 
  
Back to record